3'-aminoadenosine-5'-uronamides: Discovery of the first highly selective agonist at the human adenosine A3 receptor

Journal of Medicinal Chemistry

Volumn 46, Issue 3, 2003, Pages 353-355

  DeNinno, Michael P ^a   Masamune, Hiroko ^a   Chenard, Lois K ^a   DiRico, Kenneth J ^a   Eller, Cynthia ^a   Etienne, John B ^a   Tickner, Jeanene E ^a   Kennedy, Scott P ^a   Knight, Delvin R ^a   Kong, Jimmy ^a   Oleynek, Joseph J ^a   Tracey, W Ross ^a   Hill, Roger J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' AMINOADENOSINE 5' URONAMIDE; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE DERIVATIVE; CP 608039; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR RISK; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HEART MUSCLE ISCHEMIA; HUMAN; STRUCTURE ACTIVITY RELATION;

ADENOSINE; AMIDES; CELL LINE; HUMANS; ISOXAZOLES; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037472749     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0255724     Document Type: Article

References (22)

1. Mangano, D. T. Perioperative cardiac morbidity. Anesthesiology 1990, 72, 153-184.
2. (a) Eagle, K. A.; Rihal, C. S.; Mickel, M. C.; Holmes, D. R.; Foster, E. D.; Gersh, B. J. Cardiac risk of noncardiac surgery. Circulation 1997, 96, 1882-1887.
3. (b) Ashton, C. M.; Petersen, N. J.; Wray, N. P.; Kiefe, C. I.; Dunn, J. K.; Wu, L.; Thomas, J. M. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann. Intern. Med. 1993, 118, 504-510.
4. (c) Goldman, L. Cardiac risks and complications of noncardiac surgery. Ann. Intern. Med. 1983, 98, 504-513.
5. Murray, C. E.; Jennings, R. B.; Reimer, K. A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74, 1124-1136.
6. (a) Thornton, J. D.; Liu, G. S.; Olsson, R. A.; Downey, J. M. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 1992, 85, 659-665.
7. 1 selective agonist, 2-chloro-N6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in rabbits. Cardiovasc. Res. 1993, 27, 652-656.
8. (a) Liu, G. S.; Richards, S. C.; Olsson, R. A.; Mullane, K.; Walsh, R. S.; Downey, J. M. Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc. Res. 1994, 28, 1057-1061.
9. (b) Tracey, W. R.; Magee, W.; Masamune, H.; Kennedy, S. P.; Knight, D. R.; Buchholz, R. A.; Hill, R. J. Selective adenosine A3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovasc. Res. 1997, 33, 410-415.
10. 3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ. Res. 1997, 80, 800-809.
11. (a) Gallo-Rodriguez, C.; Ji, X. D.; Melman, N.; Siegman, B. D.; Sanders, L. H.; Orlina, J.; Fischer, B.; Pu, Q.; Olah, M. E.; van Galen, P. J.; Stiles, G. L.; Jacobson, K. A. Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists. J. Med. Chem. 1994, 37, 636-646.
12. 3 adenosine receptors. J. Med. Chem. 1994, 37, 3614-3621.
13. (c) Siddiqi, S. M.; Jacobson, K. A.; Esker, J. L.; Olah, M. E.; Ji, X.-l.; Melman, N.; Tiwari, K. N.; Secrist, J. A., III; Schneller, S. W.; Cristalli, G.; Stiles, G. L.; Johnson C. R.; Ijzerman, A. P. Search for new purine- and ribose-modified adenosine analogs as selective agonists and antagonists at adenosine receptors. J. Med. Chem. 1995, 38, 1174-1188.
14. (d)Jacobson, K. A.; Siddiqi, S. M.; Olah, M. E.; Ji, X.-d.; Melman, N.; Bellamkonda, K.; Meshulam, Y.; Stiles, G. L.; Kim, H. O. Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors. J. Med. Chem. 1995, 38, 1720-1735.
15. 3 adenosine receptor ligands: history and perspective. Med. Res. Rev. 2000, 20, 103 -128.
16. (f) Muller, C. E. Adenosine receptor ligands - recent developments part I. Agonists. Curr. Med. Chem. 2000, 7, 1269-1288.
17. 3 adenosine receptor. Bioorg. Med. Chem. Lett. 2001, 11, 1931-1934.
18. 3 receptor antagonists. Trends Pharmacol. Sci. 2000, 21, 456-459.
19. (i) Jacobson, M. A. Adenosine receptor agonists. Expert Opin. Ther. Pat. 2002, 12, 489-501.
20. 3 receptor and its ligands. Prog. Med. Chem. 2001, 38, 61-113.
21. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 1994, 15, 298-306.
22. Niedballa, U.; Vorbrüggen, H. A general synthesis of N-glycosides. I. Synthesis of pyrimidine nucleosides. J. Org. Chem. 1974, 39, 3654-3660.